Cochrane Methods Executive seeks one new Methods Group Convenor representative

Cochrane Methods Executive seeks one new Methods Group Convenor representative

Posted 19-04-2023 by Ingrid Arevalo-Rodriguez (Methods Implementation Editor)

We seek nominations for one vacant position on the Cochrane Methods Executive, to start in September 2023. Please note the deadline is *Wednesday, 31 May 2023*.

What is the Methods Executive?

The Methods Executive provides a leadership forum and general oversight on Cochrane's key methodological roles and methods-related activity. Members take strategic responsibility for supporting Cochrane's Editor-in-Chief, representing Cochrane's Methods Groups, and improving communication between different Cochrane groups and structures with related methods interests. Key responsibilities of the Methods Executive include:

  • Act as a voice for the methods community within Cochrane, such as for Methods Groups, liaising with Cochrane Central Executive Team.
  • Seek to ensure Cochrane is informed of important new methods (and improvements to existing methods) that should be considered for use in Cochrane.
  • Oversee new methods proposals to Cochrane.
  • Provide guidance and advice to the Editor in Chief and Editorial Board on devising and implementing strategies to improve the methodological quality of Cochrane Reviews and developing strategic methodological priorities in Cochrane. 
  • Provide strategic assistance in the management of methods development and training. 
  • Make decisions on methods-related activities in Cochrane, including the topic, organisation and delivery of the annual Methods Symposium.
  • Oversee the Methods Groups. 
  • Promote Cochrane methods to the wider methods community and represent Cochrane externally on methodological issues or queries.

The Methods Executive is comprised of six elected Methods Group Convenors, which currently include Su Golder (Adverse Effects), Tianjing Li (Comparing Multiple Interventions), Carl Moons (Prognosis), Chantelle Garrity (Rapid Reviews), Jo McKenzie and Areti Veroniki (Statistics). Other roles on the Methods Executive include representation on Cochrane's Editorial Board (currently Jane Noyes), Cochrane Handbook Editor (currently Tianjing Li), Cochrane Evidence Synthesis and Methods Journal (currently Michael Brown), and Cochrane Council representatives, Silvia Minozzi and Cinzia Del Giovanne. The Methods Implementation Editor, the Methods Support Unit Manager, the Editorial Product Lead and the Head of Engagement, Learning and Support serve in ex-officio roles. The Chairs of the Methods Executive are currently Tianjing Li and Areti Veroniki.

The Methods Executive has a three-year standard tenure for elected Methods Group Convenors, with annual nominations for vacancies each year. Once elected, Methods Group Convenors can remain in position for up to a maximum of two tenures (six years).

Details of the open position on the Methods Executive 

The open position of the Methods Executive will fill vacancies from Jo McKenzie (Statistics), who will rotate off at the end of 2023. 

We seek an experienced, well-established Methods Group Convenor for appointment from September 2023. Candidates will have strong connections within the Cochrane community. Along with their specialist expertise, they will be skilled in systematic review methodology; experience on similar committees is an advantage. Methods expertise from elected members of the Methods Executive currently covers Comparing Multiple Interventions, Statistics, Rapid Reviews and Prognosis. Therefore, we particularly encourage Convenors from other Methods Groups to step forward.

If elected, we expect members to attend meetings regularly, typically every two months by teleconference. We also expect them to contribute to issues that arise by e-mail between meetings. 

Apply here